Take Action: Iluvien Survey for Diabetic Macular Edema (DME)

Are you a person living with Diabetic Macular Edema (DME) or a caregiver for a person living with DME? The International Federation on Ageing (IFA), in partnership with the Canadian Council of the Blind (CCB), Diabetes Canada and the Canadian Association for Retired Persons (CARP), have launched a survey to get your feedback!

The purpose of the survey is to gather vital information to populate a Patient Input Template to the Common Drug Review (CDR) for Iluvien (fluocinolone acetonide intravitreal implant), a medication recently approved by Health Canada. CDR is empowered to recommend to provincial and territorial governments whether Iluvien should be publicly funded for DME patients.

Take Survey Now

You do not need to have taken Iluvien to respond to this survey. It should take only about 15 minutes to complete. Your input is vital to this process and to helping to ensure access to this treatment.

Your responses will NOT be personally identified. All responses will be anonymously summarized as part of the overall submission to CDR. The survey closes on Friday April 19, 2019.

If you have any questions about this survey, please contact Dr Jane Barratt at jbarratt@ifa-fiv.org.

Pneumonia Vaccination in LTC settings in Canada Banner

Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings.

The ‘Driving the agenda of pneumococcal pneumonia vaccination in at-risk populations in community and long-term care’ study was conducted to understand the status of existing public health policies and campaigns on pneumococcal disease in community and long-term care settings and its implications on the uptake of pneumococcal vaccination. The report highlights policy gaps for pneumococcal vaccination across long-term care settings in Canada and accordingly provides recommendations for policy improvements.

Pneumococcal disease is a leading cause of hospitalization and mortality in Canada. There is a high prevalence of this disease amongst populations that are most at-risk of serious complications from infection, such as older adults in long-term care settings. Check out the technical report to learn more.

Download the Technical report

27 April 2023, Toronto, ON – The International Federation on Ageing (IFA) is proud to release findings from a recent study entitled Driving the agenda of pneumococcal pneumonia vaccination in at-risk populations in community and long-term care. Check out the technical report to learn more.